Walleye Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,800
Closed -$163K 4890
2025
Q4
$163K Buy
16,800
+14,000
+500% +$119K ﹤0.01% 3642
2025
Q3
$11.7K Buy
+2,800
New +$17.9K ﹤0.01% 4268
2024
Q1
Sell
-1,000
Closed -$8.43K 5819
2023
Q4
$8.43K Buy
+1,000
New +$11.6K ﹤0.01% 4586

Other funds holding REPL

Walleye Capital's REPL Position: Q1 2026 in Review

Walleye Capital opened a new position in Replimune Group (REPL) in Q1 2026: 71,592 shares worth $548K. The stake represents ﹤0.01% of the portfolio and ranks #2592 among its holdings. This is a return to the name: Walleye Capital previously reported a position in REPL as recently as Q3 2025.

Walleye Capital first reported a position in REPL in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.18M in Q2 2023. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Walleye Capital held 71,592 shares of Replimune Group worth $548K as of Q1 2026.
  • Replimune Group was a new Walleye Capital position in Q1 2026.
  • Replimune Group made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2592 holding.
  • Walleye Capital first reported a position in Replimune Group in Q2 2023 and has held it in 6 quarters since.
  • Walleye Capital's Replimune Group position peaked at $1.18M in Q2 2023.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.